ChemoCentryx
CCXI
#3567
Rank
NZ$6.47 B
Marketcap
NZ$90.01
Share price
0.00%
Change (1 day)
30.28%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI)

Last known market cap: NZ$6.47 Billion

On November 25, 2022 ChemoCentryx had a market cap of NZ$6.47 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$5.88 B57.76%
2021NZ$3.73 B-37.15%
2020NZ$5.93 B67.9%
2019NZ$3.53 B329.36%
2018NZ$0.82 B101.65%
2017NZ$0.40 B-20%
2016NZ$0.51 B-2.34%
2015NZ$0.52 B38.08%
2014NZ$0.37 B25.33%
2013NZ$0.30 B-37.5%
2012NZ$0.48 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Biogen
BIIB
NZ$44.39 B 585.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$694.02 B 10,621.23%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$171.57 B 2,550.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
NZ$190.98 B 2,850.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$860.79 B 13,197.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$305.20 B 4,614.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$247.95 B 3,730.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$60.28 B 831.24%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
NZ$437.14 B 6,652.98%๐Ÿ‡บ๐Ÿ‡ธ USA